"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 29 | 7 | 36 |
| 1995 | 34 | 4 | 38 |
| 1996 | 26 | 7 | 33 |
| 1997 | 36 | 4 | 40 |
| 1998 | 49 | 4 | 53 |
| 1999 | 31 | 6 | 37 |
| 2000 | 48 | 10 | 58 |
| 2001 | 51 | 3 | 54 |
| 2002 | 65 | 5 | 70 |
| 2003 | 64 | 12 | 76 |
| 2004 | 46 | 6 | 52 |
| 2005 | 60 | 8 | 68 |
| 2006 | 76 | 11 | 87 |
| 2007 | 68 | 5 | 73 |
| 2008 | 81 | 5 | 86 |
| 2009 | 66 | 6 | 72 |
| 2010 | 81 | 10 | 91 |
| 2011 | 102 | 9 | 111 |
| 2012 | 88 | 7 | 95 |
| 2013 | 83 | 10 | 93 |
| 2014 | 82 | 20 | 102 |
| 2015 | 82 | 10 | 92 |
| 2016 | 78 | 12 | 90 |
| 2017 | 108 | 7 | 115 |
| 2018 | 98 | 8 | 106 |
| 2019 | 78 | 6 | 84 |
| 2020 | 99 | 8 | 107 |
| 2021 | 84 | 6 | 90 |
| 2022 | 82 | 2 | 84 |
| 2023 | 72 | 3 | 75 |
| 2024 | 62 | 12 | 74 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024. Semin Radiat Oncol. 2025 Jan; 35(1):110-125.
-
Association between non-melanoma skin cancer, psoriasis, and immunomodulatory therapy: a national epidemiologic study. Arch Dermatol Res. 2024 Dec 12; 317(1):101.
-
BPDCN: state of the art. Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):279-286.
-
Diet and Immune Effects Trial (DIET)- a randomized, double-blinded dietary intervention study in patients with melanoma receiving immunotherapy. BMC Cancer. 2024 Dec 04; 24(1):1493.
-
Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
-
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas. J Immunother Cancer. 2024 Nov 12; 12(11).
-
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precis Oncol. 2024 Nov; 8:e2400375.
-
Small-Molecule CCR4 Antagonists in Cutaneous T-cell Lymphoma. Cancer Res Commun. 2024 Oct 01; 4(10):2756-2765.
-
Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early-Stage Malignant Melanoma. Cancer Med. 2024 Oct; 13(19):e70313.
-
Epidemiology of dermatofibrosarcoma protuberans among Asian-American sub-groups: a population-based study of the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol Res. 2024 Sep 26; 316(9):637.